期刊文献+

淋巴管生成因子LYVE-1及Prox-1在宫颈鳞癌组织的表达及意义 被引量:2

Expression of LYVE-1 and Prox-1 in cervical squamous cell carcinoma.
暂未订购
导出
摘要 目的:探讨淋巴管生成因子LYVE-1及Prox-1的定量表达与宫颈癌淋巴结转移的相关性。方法:收集宫颈鳞癌手术标本24例,运用半定量RT-PCR技术对淋巴管生成因子LYVE-1和Prox-1进行分析,分别比较这两种因子在切除标本的肿瘤组织、癌旁组织中表达的差异。结果:Prox-1在肿瘤及癌旁组织表达分别为1.52±0.26和0.46±0.19,LYVE-1在肿瘤及癌旁正常组织的表达分别为1.37±0.21和0.56±0.12。Prox-1及LYVE-1在肿瘤组织的表达均高于癌旁组织(P均<0.01),与肿瘤的发生有关。并且它们的表达与淋巴结转移有相关性(P<0.01)。结论:Prox-1及LYVE-1表达升高与宫颈癌发生及淋巴结转移有一定关系,检测该指标对了解宫颈癌的侵袭和转移具有一定价值。 Objective: To investigate the relevance between the expression of lymphangiogenesis factor and cervical lymph node metastasis. Method:This study has collected 24 cases of surgical specimens of cervical squamous cell carcinoma'with lymph node metastasis,using semi-quantitatie reverse transcription PCR technique to analyse the expression of lymphangiogenic factor LYVE-l and Prox-J, and compared the differential expression of these two factors in tumor and adjacent tissue respectively. Results:The relative expression of Prox-1 in tumor and tissue adjacent to the tumor were 1.52±0.26 and 0.46±0.19(P〈0.01 ) ,of LYVE-1 were 1.37±0.21 and 0.56±0.12 (P〈0.01). They had higher expression in cervical tissues than adjacent tissues, related with the development of cervical cancer and lymph node metastasis. Conclusion:Prox-1 and LYVE-l were correlated with cervical cancer and lymph node metastasis,suggesting that detection of LYVE-1 and Prox-1 may be valuable in the evaluation of invasiveness and metastasis of cervical cancer.
出处 《现代妇产科进展》 CSCD 北大核心 2011年第5期365-368,共4页 Progress in Obstetrics and Gynecology
关键词 宫颈癌 淋巴管内皮标记物 PROX-1 LYVE-1 Cervical cancer Lymphatic endothelial marker Prox-1 LYVE-1
  • 相关文献

参考文献15

  • 1Dumoff KL,Chu C,Xu X,et al. D2-40 immunoreactivity correlates with lymphatic invasion and nodalmetastasis in early-stage squamous cell carcinoma of the uterine cervix [ J ]. Mod Pathol, 2005,18 ( 1 ) : 97-104.
  • 2张建平,吕卫国,陈怀增,周彩云,谢幸.早期宫颈鳞癌患者微淋巴管的分布及其临床意义[J].中华医学杂志,2005,85(22):1551-1554. 被引量:12
  • 3Kato T, Prevo R, Steers G, et al. A quantitative analysis of lymphatic vessels in human breast cancer, based on LYVE-1 immunoreactivity [ J ]. Br J Cancer, 2005,93 ( 10 ) : 1168-1174.
  • 4Renyi-Vamos F, Tovar J, Fillinger J, et al. Lymphangiogenesis correlates with lymph node metastasis, prognosis, and angiogenic phenotype in human non-small cell lung cancer[ J ]. Clin Cancer Res,2005,11 (20) :7344-7353.
  • 5Longatto-Filho A, Pinheiro C, Pereira SM, et al. Lymphatic vessel density and epithelial D2-40 immunoreactivity in pre-in-vasive and invasive lesions of the uterine cervix [ J ]. Gvnecol Oncol. 2007.107 ( 1 ) : 45-51.
  • 6Gao P,Zhou GY,Zhang QH, et al. Clinicopathological significance of peritumoral lymphatic vessel density in gastric carcinoma [ J ]. Cancer Lett,2008,263 ( 2 ) : 223-230.
  • 7Makinen T, Jussila L, Veikkola T, et al. Inhibition of lymphangiogenesis with resulting lympheden:a in transgenic mice expressing soluble VEGF receptor-3 [ J ]. Nat Med, 2001,7 (2) : 199-205.
  • 8Katharina S, Peter B,Verena G, et al. Prognostic value of lymphatic and blood vessel invasion in neuroendocrine tumors of the lunge [J].Am J Surg Pathol, 2005,29 ( 3 ) : 324-328.
  • 9Wigl JT,Oliver G. Prox-1 function isrequired for the development of the murine lymphatic system[ J ]. Cell, 1999,98:769-778.
  • 10Banerji S, Ni J, Wang SX, et al. LYVE-1, a new homologue of the CD44 glycoprotein,is a lymph-specific receptor for hyaluronan [ J ]. Cell Biol, 1999,144 (4) :789- 801.

二级参考文献24

  • 1张建平,吕卫国,陈怀增,周彩云,谢幸.早期宫颈鳞癌患者微淋巴管的分布及其临床意义[J].中华医学杂志,2005,85(22):1551-1554. 被引量:12
  • 2Birner P, Schindl M, Obermair A, et al. Lymphatic microvessel density in epithelial ovarian cancer: its impact on prognosis. Anticancer Res, 2000,20:2981-2985.
  • 3Dadras SS, Paul T, Bertoncini J, et al. Tumor lymphangiogenesis: a novel prognostic indicator for cutaneous melanoma metastasis and survival. Am J Pathol, 2003,162:1951-1960.
  • 4Kim H, Dumont DJ. Molecular mechanisms in lymphangiogenesis: model systems and implications in human disease. Clin Genet, 2003,64:282-292.
  • 5He Y, Karpanen T, Alitalo K. Role of lymphangiogenic factors in tumor metastasis. Biochim Biophys Acta, 2004,1654:3-12.
  • 6Benedet JL, Bender H, Jones III H, et al. FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. Int J Gynecol Obstet, 2000,70:209-262.
  • 7Weidner N. Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors. Breast Cancer Res Treat, 1995,36:169-180.
  • 8Franchi A, Gallo O, Massi D, et al. Tumor lymphangiogenesis in head and neck squamous cell carcinoma: a morphometric study with clinical correlations. Cancer, 2004,101:973-978.
  • 9Reis-Filho JS, Schmitt FC. Lymphangiogenesis in tumors: what do we know? Microsc Res Tech, 2003,60:171-180.
  • 10Fidler IJ, Ellis LM. Neoplastic angiogenesis--not all blood vessels are created equal. N Engl J Med, 2004,351:215-216.

共引文献11

同被引文献13

引证文献2

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部